Background: Healthy young women who engage in an exercise program may lose fat that is not reflected in body weight changes because of concurrent gains in fat-free mass (FFM). Objective: This study addressed the question of how well anthropometry-based predictive equations can resolve these changes. Design: Several widely used skinfold-thickness-or circumference-based equations were compared by using dual-energy X-ray absorptiometry to study 150 healthy young women before and after 8 wk of Army basic combat training (average energy expenditure: 11.7 MJ/d). Results: Women lost 1.2 ± 2.6 kg fat (x -± SD) and gained 2.5 ± 1.5 kg FFM. Fat loss (r = 0.47), but not FFM gain (r = 0.01), correlated with initial fatness. Thus, for many women who lost fat, body weight did not change or increased. Fat loss was associated with a reduction in abdominal circumference but this alone was not a consistent marker of fat loss. One circumference equation and one skinfold-thickness equation yielded the smallest residual SDs (2.0% and 1.9% body fat, respectively) compared with the other equations in predicting body fat. The sensitivity and specificity of the best equations in predicting changes in percentage body fat were not better than 55% and 66%, respectively. Conclusions: These data suggest that for women, anthropometry can provide better estimates of fatness than body mass index but it is still relatively insensitive to short-term alterations in body composition. Not surprisingly, the circumference equation that includes the most labile sites of female fat deposition (ie, waist and hips instead of upper arm or thigh) proved to be the most reliable.
INTRODUCTION
Young men and women in a physical training program can show beneficial changes in their body composition, such as reductions in body fat and increases in muscle mass (1) . Body weight is not a suitable measure for assessing these changes because an increase in weight due to an increase in fat-free mass (FFM) can be misinterpreted as an increase in body fatness. To correctly identify changes and to provide positive and correct feedback, it is necessary to be able to assess progress without the use of expensive equipment or technically complex procedures. For men, fat loss is well represented by a simple decrease in the abdominal girth measurement, even for the leanest men (2) . For women, there is no equivalent single site of fat deposition that adequately represents fat loss; changes occur in the thighs, hips, abdomen, and upper arms (3) . Skinfold thicknesses may also be inadequate reflections of total body fat change because visceral fat cannot be measured and limb circumference measurements are complicated by concomitant changes in the underlying muscle mass. A simple method for assessing fat loss would be useful to the many individuals who engage in fitness programs. This has particular importance to women in occupations in which weight or fat standards are imposed to motivate fitness and good nutrition habits for the prevention of obesity. For example, in the US Armed Forces, all members are weighed at least annually to ensure compliance with weight control regulations (4) . Individuals who exceed an established weight-for-height limit are then assessed for percentage body fat by using circumference-based prediction equations. Overfat service members are encouraged to achieve standards through a reasonable program of exercise and dietary modification, and they risk separation from the military if they do not make satisfactory progress toward meeting the standards (5, 6) .
Anthropometrically based prediction equations have not been rigorously tested in men or women for their ability to detect bodycomposition changes. Several reports commented on the inadequacy of various skinfold-thickness equations to predict changes in body composition, whether modest (7, 8) or large (9, 10) . Abdominal circumference is responsive to reduction in fat energy stores in men, and neck circumference provides an adjustment factor for body size or lean mass changes (2, 11) . However, there is no such simple set of predictive measurements for women, whose principal sites of fat deposition and responsiveness to fat mobi-lization vary according to genetics, hormonal influences, and the reproductive life cycle (12, 13) . Because typical fat depots in women (ie, hips, thigh, abdomen, and upper arm) may not be equally responsive to exercise, the measurement sites that best predict adiposity in an individual at one point in time may not even be the same sites that best detect change in fat weight.
The goal of the present study was 2-fold. First, changes in body composition during 8 wk of intense exercise training as part of the basic combat training (BCT) program were determined in healthy women. Factors such as initial body fat, previous pregnancy, and ethnicity were investigated in relation to the changes. Second, the ability of existing anthropometry-based equations for women to detect changes in percentage body fat in these women was evaluated.
SUBJECTS AND METHODS

Experimental design
The research protocol for this study was approved by the Human Use Review Committee of the US Army Research Institute of Environmental Medicine, Natick, MA, and by the Human Use Review Office of the US Army Medical Research and Materiel Command, Fort Detrick, Frederick, MD. The study subjects were volunteers from an all-woman basic training unit at Fort Jackson, SC, in the spring of 1993. Prospective study subjects were informed of the purposes, risks, and benefits of the study, and those who volunteered to participate gave their written consent before the study.
Data were collected at the start and the end of the training, with 56-59 d between measurements. BCT is 8 wk in duration and includes orientation of new recruits to soldier skills with an intensive period of physical training. Average energy requirements during training totaled 11.7 MJ/d, on the basis of careful assessments of intakes of a subsample of subjects (n = 40) and body energy balance calculations. Additional data from the parent study, of which this study was one part, is available in a technical report (14, 15) .
Study subjects
Complete data were available for 150 women before and after BCT. Descriptive characteristics of the subjects are summarized in Table 1 . The mean (± SD) age of the participants was 21.4 ± 3.6 (17-33) y; 57% identified themselves as non-Hispanic white (n = 87), 25% as black (n = 41), and 13% as Hispanic (n = 19). On arrival at BCT, 19 .1% of the women were smokers; all were required to quit abruptly because smoking is not permitted during the 8 wk of BCT. At the start of BCT, 28% of the women exceeded Army female body-composition standards. These standards involve screening tables based on body mass index (BMI; in kg/m 2 ) and then an upper limit of percentage body fat predicted by the Army circumference-based equation. For the youngest women (18-20 y of age), the weight screen threshold that prompts a percentage body fat assessment is a BMI value of 23.5; the upper limit for percentage body fat is 30%. For the next age group (21-27 y), these values are 24.3 and 32% body fat, respectively. Many participants in this study were unaware of their status with respect to Army body-composition standards, and 18% of recruits still exceeded the Army standards by the end of BCT. Soldiers who exceed the standard are required to lose weight to achieve the body fat standards within 6 mo of their arrival at their first unit of assignment.
Menstrual history indicated that only 15% of the soldiers had ever missed a period unrelated to pregnancy; in general, women who are not eumenorrheic are rejected from service on the basis of medical standards of fitness (16) . Thirty-five percent of the women had been pregnant previously (n = 54), and 23% were using contraceptive steroids, primarily norethindrone, levonorgestrel, and norgestrel combined with low-dose ethinyl estradiol, as well as levonorgestrel implants (n = 4). BCT did not suppress or lengthen menstrual cycles, on the basis of daily self-reported menses and the absence of a change in pre-, mid-, and posttraining mean serum estradiol and progesterone concentrations (17) .
Anthropometry and body composition
Anthropometric measurements were performed before and after BCT. Height was measured with a calibrated anthropometer (GPM no. 101; Seritex Inc, Carlstadt, NJ). The women were dressed in physical training uniforms (T-shirts and shorts) during the measurement sessions. Body weight was measured by using electronic balances calibrated onsite and accurate to 0.04 kg. Measurements included 15 circumferences (neck, shoulders, chest, abdomen at the natural waist, abdomen at the navel, abdomen at the iliac crest, hips, thigh, biceps flexed, biceps, forearm, wrist, knee, calf, and ankle) and 9 skinfold thicknesses (chest, subscapular, triceps, biceps, midaxillary, suprailiac, abdominal, thigh, and calf). Eight circumference and 6 skinfold-thickness measurements are reported here; more detail is available in the technical report (14) . Circumference measurements were taken in duplicate by using a 0.25-in (Ϸ0.64 cm) wide fiberglass tape measure; skinfold thicknesses were made in triplicate by using block-calibrated Harpenden calipers (British Indicators, Ltd, London). All measurements were made on the right side of the body by using techniques 
Statistical analysis
Descriptive statistics including means, SDs, minimums, and maximums were computed for each body-composition variable from DXA and for anthropometric measurements for all ethnic groups combined before and after BCT. Descriptive statistics for the changes in these variables before and after BCT were also computed. Significant tests for these changes were performed by using paired t tests. Analysis of variance was performed to evaluate ethnic group differences and the effects of previous pregnancy on the baseline measures and the changes. Changes in percentage body fat, TBF, and FFM were regressed against baseline percentage body fat to evaluate the effects of baseline body fat on subsequent changes in body composition. Five commonly used prediction equations for women were used to estimate percentage body fat (19) (20) (21) (22) (23) . We also formulated an equation for predicting percentage body fat from selected anthropometric measurements in the present study. Detailed procedures for deriving this equation were described elsewhere (24); briefly, all possible subsets of regression with selection criteria: minimum root mean square errors, minimum Cp (an index of the appropriate number of independent variables in an equation), and significant regression estimates at P < 0.05 were used.
The sensitivity and specificity of these equations were calculated. The sensitivity is the conditional probability of detecting changes in percentage body fat with the equation, assuming there are significant changes in the observed data; specificity is the conditional probability of no changes in percentage body fat as detected by the equation given there are no significant changes in the observed data.
RESULTS
Physical characteristics at the start of BCT
The mean body weight, height, and other anthropometric data for this sample of women at the start of BCT are shown in Table 1 . There were 54 women (35%) who were pregnant previously. There were no significant differences in body composition, circumferences, or skinfold thicknesses with previous pregnancy except that women who had been pregnant (age: 22.7 ± 1.5 y) tended to be older than women who had never been pregnant (age: 20.6 ± 2.9 y) and they had a smaller mean thigh skinfoldthickness measurement (P < 0.05). Ethnic group differences in anthropometric and body-composition variables for white (n = 87), black (n = 41), and Hispanic women (n = 19) were compared by analysis of variance. No major differences were found except for height and FFM (blacks > non-Hispanic whites > Hispanics). These 2 measures remained significantly different at the end of training.
Changes as a result of BCT
In general, the fat variables decreased during BCT whereas the FFM variables increased ( Table 2) . Weight increased significantly (P < 0.05) during BCT by 0.8 ± 2.9 kg. Values for BMI increased significantly by 0.2 ± 1.1. The increase in weight during BCT was due mainly to an increase in FFM (2.5 ± 1.5 kg), with a smaller mean decrease in TBF (1.2 ± 2.6 kg). Evaluation of the physical training effects based only on body weight could be misinterpreted because the conventional reason for an increase in weight is an increase in fat. BCT also resulted in a decrease in waist-to-hip ratio of 0.01 ± 0.03 (P < 0.05). There was a significant increase in some circumferences after BCT and a decrease in skinfold thicknesses at various sites. When data only from those women who lost fat weight were examined, the abdominal circumference measurements stood out with significant decreases compared with significant increases in most of the other circumference measurements (data not shown).
Regressions of changes in weight, TBF, and FFM on baseline percentage body fat were performed separately (Figure 1 ). The recruits with the highest percentage body fat at baseline lost the largest amount of fat weight (r = 0.47), but there was no relation between increase in FFM during BCT and initial percentage body fat. The recruits with the highest percentage body fat at baseline also lost the largest amount of weight (r = 0.39). Effects of a previous pregnancy on the changes in body composition after BCT were examined and no significant differences were noted in women who had been pregnant.
Application of existing equations for percentage body fat
Selected existing prediction equations were applied to the data and the SDs of the residual were computed. The equations used were those developed for the Marine Corps (19) , the Navy (20) , and the Army (21) on the basis of samples from each of these respective services and the frequently cited equations of Durnin and Womersley (22) and Jackson et al (23) ( Table 3) . The resulting mean residuals and residual SDs for each equation, by ethnic group, are presented in Table 4 . There were no differences by previous pregnancy status (data not shown). Equations that used body density as the dependent variable were PREDICTING WOMEN'S CHANGE IN BODY FAT 271 (Table 5) . When the residual SDs were separated by whether the women had previously been pregnant, the Navy equation performed significantly better than did the other circumference-based equations (data not shown).
Testing the sensitivity of the equations in detecting changes
Ideally, a prediction equation should be sufficiently precise to detect changes in the predicted variables over time. The sensitivity to detect changes in percentage body fat was evaluated and is summarized in Table 6 . All the equations had relatively low sensitivity (Figure 3) . Among the observed significant changes, the proportions of changes detected by the existing equations were between 12% and 55% for body fat. The specificity was in general greater than the sensitivity. The values for specificity ranged from 48% to 86% for body fat. There were no effects of a previous pregnancy on the sensitivity and specificity of these prediction equations. Even the equation developed from the data collected at the start of BCT did not have better sensitivity or specificity than some of the other existing equations for detecting change during BCT.
DISCUSSION
Body weight is not an effective or accurate way to assess the results of a physical training program. Several women either gained weight or had little weight change after 8 wk of BCT, even though they lost body fat. This effect was due partly to the results of a desirable change: an increase in FFM that averaged 2.5 kg. The fattest women lost the greatest amount of fat and weight. Women who had between 25% and 35% body fat were the ones most likely to register little or no change in weight when they may have actually lost several kilograms of fat. Regardless of their initial percentage body fat, all of the women tended to gain FFM. There were no ethnic differences in the predictability of body composition or changes in body composition.
Direct measures of percentage body fat and FFM are currently impractical for widespread use in screening for general health and fitness standards. Indirect or clinical methods usually rely on estimation of body composition from easily measured variables such as circumferences or skinfold thicknesses and use of prediction equations. Anthropometric measures provide convenient estimates of body fat in individuals; however, these predictions have not been developed or validated for prediction of change in body composition. Furthermore, body fat prediction from one or more regional measurements of fat deposition is more difficult in women than in men (in whom the abdominal site provides a single reliable focus). In a previous sample of 237 women, abdominal circumference alone characterized the fattest women (> 34% body fat), but average proportions for all other women remained similar between abdomen, hips, thigh, and biceps (3). This suggests that abdominal circumference in women distinguishes only those above some threshold of body fat or has greater individual variation than does the direct relation between adiposity and abdominal circumference in men. Note that in the current study, the best circumference equation for body fat estimation and prediction of change in body fat assesses both waist and hip circumferences (20) . It is convenient that these are the 2 sites that are most susceptible to environmental (ie, diet and exercise) changes, compared with the upper arm and thigh fat depots, which are more influenced by pregnancy and postpartum hormones (3).
Cross-validation of the existing equations with the data in this study indicated relatively large errors in the prediction of percentage body fat ranging from between 3.5% and 8.1%. This implies that exercise training would have had to produce a minimum change in percentage body fat of 3.5-8.1% (depending on the equations applied) to register a change with use of these equations. Our results also indicated a lack of sensitivity and specificity of these existing prediction equations in detecting changes in body composition. Change in the criterion method for body-composition assessment may account for some of the error in body fat estimation but should not play an important role in prediction of relative changes (ie, prediction of body fat change with use of these equations is not likely to be better when compared with underwater weighing instead of DXA). In fact, the use of DXA as the criterion method would be expected to reduce some of the prediction variability of these equations because both DXA and the circumference measurements are free of the variability produced by differences in bone density. This is not the case for the 2-compartment-model interpretations of hydrodensitometry, against which each of the equations was originally calibrated, and hydrodensitometry measurements also produce body fat estimates with the lowest precision (26). Ethnic group differences can potentially affect the performance of the existing equations. Nonetheless, in the present study, we did not find ethnic group differences in anthropometry and body composition in our sample. Statistical analysis of the existing equations was also performed separately for each ethnic group and for all ethnic groups combined. The results of crossvalidation for the combined set were similar to those for the ethnic groups separately. In the present study, the number of blacks and Hispanics was small and this may have contributed to our findings of no major ethnic group differences.
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Body-composition assessment in the US military is a 2-tiered process. Personnel who exceed the weight-for-height limits are required to receive a second evaluation. The second evaluation involves an individual percentage body fat estimation made with use of prediction equations for percentage body fat derived from underwater weighing. Body fat standards have been enforced in the military services since the early 1980s (5), when the Marine Corps (19) , the Navy (20) , and the Army (21) each developed their own percentage body fat equations. For men, each of these equations measured the abdominal circumference at the umbilicus and used the neck circumference as an adjustment for body size or FFM (11) . For women, the equations were considerably more complex and each of the military services produced their own equations that relied on different circumference measurements to capture fat stores, emphasizing thigh and abdomen (19) , hips and abdomen (20) , or hips and body weight (21) . Each of these equations also had factors that adjust for body size or FFM. The skinfold-thickness equations of Durnin and Womersley (22) were used by the Army as an interim method while a circumferencebased equation was being developed. This experience showed the difficulty of standardizing measurements by using a method with any complexity in technique such as skinfold-thickness measurement, although standardization of seemingly simple circumference measurements has also proven to be a challenge, both in tape handling and proper landmark identification. Currently proposed revisions of the fitness and body composition directive for all military services require adoption of an equation that uses the measurement sites used in the equation developed by the Navy; the US Marine Corps has already adopted an equation using the recommended measurement sites.
The present study highlights the challenge faced by the military in evaluating body composition in servicewomen. Even if BMI proved to be a satisfactory estimate of adiposity in women (because of smaller variability in lean mass compared with hypertrophic responses to exercise in men), modest success in weight loss programs would not be adequately reflected in body weight changes. Methods for assessing fat change, such as the current predictive equations, increase the likelihood of detecting actual fat weight loss. Some of these circumference-based equations may categorize individuals with excess fat reasonably well but may not adequately predict compliance with standards after a period of fat loss. This requires, at a minimum, that changes in either weight or fat prediction be accepted as measures of progress in fat loss, and marked changes should not be expected within short intervals (ie, assessments repeated in < 6-8 wk are unlikely to reflect actual progress).
The present findings suggest that, for healthy young nonobese women, 1) a change in body weight alone is not a good measure to assess the effectiveness of physical training programs because a lean mass gain can mask fat weight loss (but reduction in body weight would strongly suggest fat weight loss), 2) the circumference-based equation of Hodgdon and Beckett (Navy) and the skinfold-thickness-based equation of Durnin and Womersley are the best of the equations tested for predicting body fat in this sample of women, and 3) none of the equations tested were very accurate in detecting changes in percentage body fat in women after physical training.
We are grateful to the young soldiers whose willing participation made this study possible. We thank Bob Mello and Sabrina Carson for their assistance in data collection. Derivation 
Letters to the Editor
Dietary treatment of iron deficiency?
Dear Sir:
We read with great interest the article by Patterson et al (1) published recently in the Journal. In the conclusion of their abstract, the authors purport to have shown that "in iron-deficient women of childbearing age, a high-iron diet produced smaller increases in SF [serum ferritin] than did iron supplementation but resulted in continued improvements in iron status during a 6-mo follow-up."
Certainly, the iron-deficient women in the diet group were advised to consume a diet high in absorbable iron for the first 12 wk of the study. However, they did not do this. Throughout the 12-wk intervention, there was no significant increase in either heme or nonheme iron intake; nor were there any significant changes in the intakes of vitamin C, meat, alcohol, phytate, calcium, or tea. Furthermore, 6 mo after the end of the formal intervention, bioavailable iron intake was, if anything, lower than at baseline; yet, the diet group's serum ferritin concentration was slightly (2.1 g/L) higher at the end of the 12-wk intervention and moderately higher (4.2 g/L) 6 mo after the intervention. Given that any change in the intake of dietary iron or its absorption modifiers throughout the 9-mo study was negligible, what could account for the increase in serum ferritin concentration?
It is possible that at the end of the 12-wk intervention, women in the diet group chose to take or were prescribed an iron supplement because they knew that they were iron deficient and had not received an iron supplement during the study. It is also possible that because serum ferritin is an acute-phase reactant, the small increase in mean serum ferritin concentration at follow-up resulted from the inclusion of one or more individuals with a serum ferritin concentration that was elevated because of infection.
The absence of a true control group makes it particularly difficult to conclude that the changes in serum ferritin concentration were the result of an improvement in diet. The cornerstone of scientific research into the effects of diet on nutritional status is the randomized controlled trial in which participants are randomly assigned to treatment or control groups. Without an iron-deficient control group, it is difficult to quantify the effects on iron status of factors beyond the investigators' control. For instance, it is well known that if a group of individuals is identified on the basis of a low biochemical index measured on one occasion, a subsequent measurement is likely, by chance, to be higher (ie, closer to the mean) even in the absence of any intervention effect. The only way to determine whether the increase in serum ferritin concentration in the iron-deficient diet group in this study was real, and not merely the result of a phenomenon such as regression to the mean, would be to compare it to changes in serum ferritin concentration in an iron-deficient control group. Concern about the ethics of not treating women with iron deficiency could have been minimized by recruiting women with low serum ferritin concentrations but normal hemoglobin concentrations.
In conclusion, the article does not show that dietary change is an effective treatment for iron deficiency. Rather, it strongly shows the difficulties that even motivated volunteers experience in attempting to modify their diets to increase iron absorption and suggests that iron supplementation is the most effective treatment for iron deficiency. 
Extra dietary copper inhibits LDL oxidation
Wan et al (1) fed cocoa powder and dark chocolate to subjects for 4 wk and found that LDL oxidation was inhibited in vitro. This favorable effect on cardiovascular risk status was attributed to flavonoids, a group of polyphenolic compounds with antioxidant characteristics. An increase in dietary copper during this experiment may have contributed to their results.
The Western diet often is low in copper: approximately onethird of 849 diets that were analyzed provided 1 mg/d (2). The interquartile range was 0.91-1.86 mg/d. Milk chocolate and cocoa powder are in the upper quartile of 235 foods evaluated by Lurie et al (3), ranking 186 and 232, respectively, in copper concentration. Calculations using Lurie et al's values for chocolate and cocoa powder of 2.86 and 50.0 g/g, respectively, show that these supplements would have added nearly 1.15 mg Cu to the basal diet each day. Dark chocolate contains more copper than does light chocolate and would have increased this estimated amount even more. It seems likely that the total daily intake of copper might have been 3 times the daily estimated average requirement (0.7 mg) or twice the recommended dietary allowance (0.9 mg) for adults (4) .
Although copper salts (at 10 mol/L) and LDL are highly reactive in vitro, this phenomenon is probably irrelevant to human physiology because copper ions are virtually nonexistent (1 amol/L) in vivo (5-7). Indeed, after providing copper supplementation to middle-aged subjects, Rock et al (8) found that the subjects' erythrocytes were more resistant to oxidation in vitro. Although this improvement occurred without an increase in the activity of superoxide dismutase (EC 1.15.1.1), an enzyme that provides defense against oxidative damage, the results may indicate that the subjects ordinarily ate too little copper and had other means of defense.
Perhaps the usual copper intakes of the subjects studied by Wan et al were too low also. Their basal diet probably was low in copper because it excluded beans and soybeans, 2 foods in the top quartile (see above). Control of the diets for copper intake as well as for intakes of caffeine, cholesterol, fat, and fiber would have been informative because the increased copper intake from chocolate seems smaller than some beneficial amounts given by Rock et al (8) . Perhaps chocolate enhances the absorbability of copper.
Copper is an antioxidant nutrient for cardiovascular health (7) and has no prooxidant activity at a considerably higher intake (8) than that given by Wan et al. Diets low in copper are suggested as an explanation for much of the epidemiology and pathophysiology of ischemic heart disease (9). Chocolate is a pleasant dietary supplement. Of note is that the base diet was adequate in copper. Whether the addition of the copper from the cocoa and dark chocolate was significant and whether it contributed to the effects on LDL oxidation would need to be tested. However, it is certainly possible that the copper contributed in some way to the overall antioxidant potential of the diets and the subsequent serum antioxidant capacity.
Leslie M Klevay
US
Population estimates of folate intake from food analyses
In their article on the folate intakes of the adult Dutch population, Konings et al (1) presented calculations of folate intake based on the folate contents of foods determined by liquid chromatography (LC). The dietary folate intake of the Dutch population was estimated to be 182 ± 119 g/d. The limitations of their study, and hence possible biases in the final estimates of folate intake, require comment.
In comparison with other published data on folate intakes in European populations, the intakes presented by Konings et al (1) seem low. In the study by de Bree et al (2) , average folate intakes in European populations were reported to be 291 and 247 g/d for males and females, respectively. As part of the European Union's fifth framework project, "Folate: From Food to Functionality and Optimal Health" (3), folate intakes for populations in 7 European countries (Finland, Germany, Italy, the Netherlands, Spain, Sweden, and the United Kingdom) were estimated on the basis of each country's food consumption and food-composition data. Dietary folate intakes ranged from 217 to 310 g/d, the average being 285 ± 30 g/d for males and 230 ± 20 g/d for females.
In addition, an intercomparison study of suitable methods of analysis for food folates was organized by using 4 certified reference materials (CRMs): CRM 121 (whole-meal flour), CRM 421 (milk powder), CRM 485 (mixed vegetables), and CRM 487 (pig's liver). Nine project participants and the National Food Administration (Sweden) analyzed the samples. To increase the number of comparable results, the data from Konings previous publication (4) were included. The number of accepted results was 7-9 for each CRM, 3-4 of which were obtained by a microbiological assay (MA) and 4-5 by HPLC. One of the HPLC laboratories used microbiological detection (LC-MA). In addition, 2 HPLC laboratories determined 5-methyltetrahydrofolate only. The certified values for total folate in these CRMs were obtained by MA by a group of experienced laboratories (5).
Our findings indicate the current status of food folate analysis in Europe. The results obtained by HPLC were 27-40% lower than the microbiological results, except for pig's liver. Indeed, Konings et al also reported a difference of the same magnitude (23-27%) between the results by LC and those by MA. The within-laboratory variation was generally small (3-11%), whereas the betweenlaboratory variation was large (7-51%). Generally, folic acid and 5-methyltetrahydrofolate could be determined with satisfactory accuracy but no agreement was found for the other vitamers.
The distribution of the folate vitamers and the total folate content of CRM 485 (mixed vegetables) are presented in Figure 1 . The sum of folate vitamers was 73% of the microbiologically determined folate content for mixed vegetables but only 60% for whole-meal flour. The distribution patterns from CRMs containing several vitamers (whole-meal flour and pig's liver) varied considerably from one laboratory to another.
There are several possible explanations for the observed discrepancy. Some of the peaks in HPLC chromatograms were often masked, which made identification and accurate quantification difficult. The existence of unidentified compounds, either folate or nonfolate, was common. It is known, for example, that 5-formyltetrahydrofolate and 10-formyltetrahydrofolate can convert to 5,10-methylenetetrahydrofolate under acidic conditions (pH < 2) used in the current HPLC mobile phases. 5,10-Methylenetetrahydrofolate does not have sufficient fluorescence to be quantified accurately. However, alternate detec- tion systems, such as electrochemical or mass spectrometry, have been developed (6) .
There is also the possibility that the bacteria used in the MA gave unequal responses to the different vitamers or can be affected by some nonfolate compounds in the samples. However, the latter was evaluated on the basis of the combined LC-MA results. The data clearly show the absence of any nonfolate peaks with organism activity.
We conclude that the MA is preferred for the determination of the total folate content of foods, especially if data on individual folates is not considered necessary. Furthermore, we stress the need for careful validation of HPLC methods. Given the considerable, yet unidentified, difference between the microbiological and HPLC data, we advise caution when estimating dietary folate intakes at the population level.
Reply to Kariluoto et al
We appreciate the reaction from Kariluoto et al regarding our paper (1), particularly on the population intakes, which are based on newly established food folate data. We completely agree that this is an important issue. Kariluoto et al referred to an estimated intake of 182 ± 119 g/d for a population aged 1-92 y and compared these data with data for adults. Our estimated intakes were 173 and 215 g/d for women and men, respectively.
Kariluoto et al reported that as a part of the European Union's fifth framework project, baseline folate intakes for populations across 7 European countries were studied by using data based on each country's food-composition data. An important problem with estimating folate intakes is the lack and the unreliability of the data on folate content in food-composition tables (2) . Additionally, in 1996, a European working group, "COST 99," compared folate data in food-composition tables for some vegetables, milk, bread, and cereals from 7 European countries. Total folate was measured by microbiological assay (MA). These food folate data showed a 2-3-fold variation (PM Finglas, unpublished observations, 1996), which indicates that folate intakes cannot be compared between countries.
In an intercomparison study that analyzed 4 certified reference materials (CRMs), estimated folic acid and 5-methyltetrahydrofolate contents were comparable in 4-5 laboratories, but no agreement in the other vitamers was found. Other than our previously published results (3) , no other participating laboratory used affinity chromatography as a cleanup step before the final determination of all vitamers with HPLC. Selhub (4) and Pfeiffer et al (5) used this technique successfully earlier. It must be stressed that only this cleanup procedure is suitable for determining the folate content in food-sample extracts when HPLC is used. Anion-exchange purification alone or solid-phase extraction leaves many interfering compounds in the chromatogram, which hampers interpretation and accurate quantitation (3, 6) .
It is not correctly stated by Kariluoto et al that 5-formyltetrahydrofolate, 10-formyltetrahydrofolate, or both convert to 5,10-methylenetetrahydrofolate under acidic conditions. In particular, 10-formyltetrahydrofolate could be converted to 5,10-methenyltetrahydrofolate rapidly (ie, on column conversion) because of the low pH of the mobile phase (5).
5-Formyltetrahydrofolate also undergoes formation of 5,10-methenyltetrahydrofolate in acidic media, although at a much slower rate (5). Thus, the acidic mobile phase used is fully suitable for separation and quantification of 5-formyltetrahy-drofolate, as shown previously by Gregory et al (7) . The presence of 5,10-methenyltetrahydrofolate in our HPLC procedure was not determined by fluorescence detection as suggested by Kariluoto et al but was quantified by diode-array detection when present (3). 10-Formyltetrahydrofolate is completely oxidized to 10-formyldihydrofolate or 10-formylfolic acid during food preparation (8) . The purpose of our study was to analyze food products in the form they are consumed. Both vitamers could be quantified with the system we used (1, 3) .
It is not clear from Kariluoto et al's letter why the absence of bacterial growth by nonfolate compounds was based only on the results of 2 CRMs instead of the 4 CRMs used in the intercomparison study. This does not necessarily mean that the response of bacteria to nonfolate compounds is absent in all food matrices. According to Kariluoto et al, liquid chromatography-microbiological assay (LC-MA) showed the absence of any nonfolate peaks with organism activity, and all other peaks with microbiological activity add up to the same amount as found by HPLC in other analyses (Figure 1 of Kariluoto et al's letter). This does not explain the discrepancy between the results by HPLC and MA. One would expect equal amounts between results of LC-MA and MA if MA is preferred as the standard method. According to these results, HPLC is preferred to MA as the standard method.
The determination of folates by MA is grounded on biological activity, whereas the determination by HPLC is grounded on the actual detection of separate folate vitamers. Problems with the response of Lactobacillus casei to different folate vitamers, as reported by Phillips and Wright (9) , and the influence of nonfolate compounds on the bacterial growth response are still not refuted and might explain the difference between the HPLC and MA results.
New, accurate food-composition data for folates are needed. Our study (1) was the first comprehensive assessment of a large range of folate-containing foods. Furthermore, this study showed the effect of new analytic data for folates, including identification and quantification. In light of current knowledge, we determined all relevant folates in foods with reliable and reproducible results (3) .
With regard to the relative importance of accurate food folate data, because they are frequently used in epidemiologic analyses in which intakes are related to disease endpoints, we recommend the standardization of methods for the determination of folate in foods to ensure accurate quantification of total folate contents. HPLC should be the method of choice.
Erik JM Konings
Inspectorate for Health Protection and Veterinary Public Health PO Box 2280 5202 CG 's-Hertogenbosch Netherlands E-mail: erik.konings@kvw.nl
Lessons learned in iron intervention trials
The December 2001 issue of the Journal featured the coincident publication of 3 articles related to anemia and its partition between iron deficiency and non-iron deficiency origins among African preschoolers living in areas of endemic malaria (1-3). Our attention was drawn to the article concerning an iron-supplementation intervention trial (3), which reported difficulties and caveats reminiscent of an experience of ours in Guatemala (4).
In the planning of their study, Zlotkin et al (3) approached their power and sample-size assumptions in the following manner: "On the assumption of 90% cure rates in the drops group and 80% in the sprinkles group and with a type I error set at 0.05 and a 0.9 probability of detecting a true difference, the final sample size estimate was 286 subjects per group." They expected up to 90% of anemic Ghanaian infants and toddlers to have iron deficiency and iron-responsive anemias. This expectation raises 2 points in our minds. The first of these points is that such an expectation conflicts with the sense of the introductory section of their paper, where they state, "…we tested the hypothesis that the response to treatment of anemia would be better with 2 mo of treatment with microencapsulated ferrous fumarate sachets daily than with ferrous sulfate drops…" (3) . Both of these statements use wording that seems to refer to a one-tailed test, but with the latter statement inclining toward superiority for the sprinkles and the former statement inclining toward a 10% better efficacy for the drops. Thus, it is important that the authors clarify whether the study was powered for a one-tailed or two-tailed test of the hypothesis of dif-ference and that they specify how many degrees of freedom were assumed for the statistical comparison. This is not to question their conclusion of no difference between 58% and 56% recovery rates, but to address a conceptual point. If a one-tailed test were conducted as stated with the power assumptions, then no conclusions of superiority for sprinkles could have been possible; one would be testing an asymmetric hypothesis to find either 1) that the ferrous sulfate was 10% better than fumarate or 2) that it was not.
The second point relates to their assumptions about the magnitude of the response to anemia treatment. The actual findings in their study fell far short of their expectations for a cure rate: in the 2-mo trial, 80 mg microencapsulated ferrous fumarate added to porridge (sprinkles) cured 56.3% of the anemia, and 40 mg ferrous sulfate in elixir (iron drops) cured 57.7% of the anemia. The optimistic interpretation of this finding is that 40% of the children were compromised in their ability to respond to iron because their anemia was due to malaria, another infection, or some other micronutrient deficiency. Thus, in fact, 100% of the "truly responsive" candidates in both wings of the intervention trial were cured by the iron treatments. Such a direct and simple interpretation could be seen as being bolstered by the coincident findings in malarial areas of Kenya (1) and the Ivory Coast (2) that 22% and 44%, respectively, of the subjects with anemia did not have iron deficiency and by the authors' own findings that malaria-infected children have a 23% lower chance of responding to iron treatments than do children without malaria (3).
Unfortunately, a more complex and pessimistic interpretation seems to be more logical; this interpretation even challenges the possibility of attributing any specific fraction of the anemia response to the iron treatments in the absence of concurrent observations on a third treatment wing, which serves as a placebo control. The authors address this issue in their statement: "Because it would be unethical to provide a placebo to a child with anemia, we did not include a placebo control" (3) . Such a proclamation of ethical absolutism could be taken more seriously had it not come from 2 of the institutions that conducted one of the largest placebo-controlled trials of vitamin A and child morbidity and mortality ever conducted (5, 6) . Are we to accept that 2 mo of observation of children with hemoglobin in the 70-99-g/L range is unethical, but it is acceptable to follow children at risk of hypovitaminosis A for an entire year in a placebo trial with mortality among the outcome variables? The consequence of this doctrine for anemia research in Ghana would mean that any field team in that country must surely bring liters of iron drops along with the HemoCue apparatus and lancets in their backpacks, because teams would be obliged to treat almost all comers after any survey. This drawback is especially valid if one realizes that newer international standards for "anemia" in this age group have a cutoff of 110 g/L (7). If 65% of Ghanaian infants and toddlers in this region have a hemoglobin below the 100-g/L anemia definition used to enroll a presumably iron-responsive sample (3), over 90% might be classified as anemic with the more conventional 110-g/L criterion. It would be worth knowing what treatment, if any, was offered by Zlotkin et al to those children found on initial screening to be in the < 70-g/L range of hemoglobin (ie, severely anemic) and those found to be in the 100-109.9-g/L range (ie, mildly anemic by international standards).
Without a placebo group, moreover, we are at a loss to assess the attributable efficacy of either form of iron in this study (3) . Because all the children were chosen to be in the lower part of the hemoglobin distribution, mathematical regression to the mean would account for some of the test-retest increment in hemoglobin concentration. This regression-to-the-mean term, moreover, might be larger than anticipated, given the fact that capillary finger-stick samples were used. Morris et al (8) examined the reliability (within-individual variability) of measurements of hemoglobin concentrations in capillary blood. From samples taken from the same persons, either concurrently from different anatomical sites or on consecutive days, they showed that concentration measurements in capillary blood have lower reproducibility than do those in venous blood, which is attributable to larger biological variation with peripheral sampling than with venous sampling. Hence, those children admitted into the eligible study pool on the basis of a hemoglobin concentration just below 100 g/L at baseline might have a hemoglobin concentration just above the criterion level at the second measurement merely because of the inherent unreliability of capillary samples (8) . Another reason for the improved anemia status of the subjects may simply have been the development of the subjects during the 2 mo of the study; anemia rates tend to improve with age after infancy. Moreover, the effects of regression to the mean or asymmetrical diagnostic misclassification, in addition to developmental changes, could account for some of the observed improvements in the rates of anemia; thus, to determine the true degree of improvement in anemia attributable to the iron treatment, there would have to be a no-treatment (placebo) wing in the study design.
Aside from the issues of quantification with regard to efficacy, we also encountered a problem in the authors' evaluation of safety. The authors comment on the similarity of the 14.5% rate of diarrhea with the ferrous sulfate treatment and the 12.8% rate with the ferrous fumarate treatment (3). Although we can readily accept the conclusion of no difference between treatments with regard to diarrhea experience, the design does not provide sufficient evidence to safeguard against intrinsic adverse effects of microencapsulated ferrous fumarate. Only by knowing that a no-treatment group also had diarrhea incidence in this range could we exonerate the iron treatments of causing the gastrointestinal symptoms. With regard to the assumptions of safety for a new treatment, moreover, its comparison with a placebo is procedurally indispensable. Even if the authors offer us "efficacy relativism" in the conclusion on the basis of comparative effects with the proven therapy as the standard for anemia cure (3), we simply cannot accept this logic of "safety relativism" with regard to adverse effects. It would not be sufficient to argue that sprinkles are safe on the basis of the fact that they do not have any more adverse effects than the elixir form of ferrous sulfate. The latter is an old medication that may have been grandfathered into the pharmacopeia with safety criteria that we may not now accept for a new agent or format. For new questions of safety, comparison against no exposure would still seem to be needed at some point.
The final conundrum for the ethical imperative to treat all anemias on sight comes from the findings of the 3 previously mentioned African studies in malarial areas. In Kenya, 22% of anemic children with a median age of 19 mo did not have iron deficiency anemia (1); in the Ivory Coast, 44% of anemic children with a mean age of 49 mo did not have iron deficiency anemia (2); in Ghana, 40% of anemic children with a mean age of 13 mo did not have iron-responsive anemia (3). Malaria is not the only possible confounding factor. In our 10-wk, placebo-controlled intervention with heme iron and ferrous sulfate in children with a mean age of 21 mo in the nonmalarial Guatemalan highlands, Ϸ43% of anemic children (hemoglobin concentration < 115 g/L) had no evidence of iron deficiency (4) . Thus, if we are to believe Zlotkin et al that "it would be unethical to provide a placebo to a child with anemia," the question is what do we treat the child with to cure the anemia? Iron will work for some children, although we do not know a priori which ones; what do we offer to the rest, and when? This is not just an ethical question for investigators and their populations, who are screened for eligibility on the basis of anemia. It underlies a very important program and policy issue for micronutrient deficiency interventions in developing (and developed) countries: when is an anemia a nutritional anemia, and when is a nutritional anemia an iron deficiency anemia? The results of all of the studies from Africa and Central America cited in this letter seem to converge toward a conclusion that "close to 100%" can no longer be the answer for either question. We may be obliged to do the "unthinkable," namely, to screen and diagnose anemias before assigning treatments both in human research and in the public health domain. The experience reported in the articles from Kenya (1) and the Ivory Coast (2) provides a basis for such diagnostic screening.
Finally, the authors leave some numerical issues to be resolved. Although they reported screening 880 children and enrolling 557, in the side effects subsection of Results, they state, "Seventy-four percent (933 of 1277) of the mothers of children in the drops group," and "Diarrhea was reported in 76 of 523 ... subjects in the drops group and in 62 of 486 ... in the sprinkles group." These latter figures must represent typographical errors that were not detected in editing.
Noel W Solomons
CeSSIAM 01011 Guatemala City Guatemala
Klaus Schümann
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Reply to NW Solomons and K Schümann
The major criticism by Solomons and Schümann of our recently published study (1) was our lack of a placebo control in the protocol, although their stance on this issue is equivocal, because they also criticize previous studies that included a placebo control. We stand firmly by our decision not to include a placebo control group. We recognize the extensive international debate on this issue (2, 3) . In our study of infants in Ghana who had moderately severe anemia, subjects in a placebo group would have received no treatment, which is exactly what they would have received had they not been enrolled in the study. Yet, there is extensive literature on the adverse effects of moderately severe anemia (4) . If the current local standard therapy is to do nothing, is it justifiable to include that standard therapy as a study arm? We agree with other ethicists that the standard of providing no less than people are able to get in their own country (which often is nothing) is a standard that is too low (S Benetar, unpublished observations, 2000). We strongly believe that, in clinical research, it is not ethical to offer a "treatment" of doing nothing just because that is what otherwise would be available to the population under study.
Solomons and Schümann make mention of earlier placebocontrolled vitamin A supplementation studies in Northern Ghana by members of our research group, which were conducted between 1988 and 1991 (5, 6) . These studies formed part of a second generation of important field trials carried out in several countries that verified the landmark findings of Sommer et al (7) . At that time, there was no global policy on universal vitamin A supplementation to children; nor was there a national program in Ghana. The protocols for these trials were reviewed and approved by the relevant ethics committees and the Ministry of Health of Ghana. We believe that it is unethical to withhold treatment of anemia today, and similarly, it would be unethical today to conduct a placebo-controlled trial of vitamin A supplementation in children. This issue begs the larger question of how to identify when the global scientific community has concluded that a specific research question has been adequately answered. In the case of treatment of iron deficiency anemia, we believe that the question has been answered and that further placebo-controlled confirmation studies are both unjustifiable and unethical.
Solomons and Schümann suggest that the biological impact of our not having included a placebo control group would place them at "a loss to assess the attributable efficacy of either form of iron in this study." Statistically speaking, this is true, but is there any biological plausibility to their statistical contention? We believe there is very little. First, the study was of very short duration. What possible mechanisms would lead to significant improvement in anemia in a group receiving no intervention for 2 mo? Because we believe that the primary mechanism causing the anemia was a lack of bioavailable dietary iron, we would have to ask whether a no-intervention group could have rapidly improved their diet with more sources of bioavailable iron, such as meat or poultry. This could have happened if there had been a significant improvement in the economic status of families in the region-for example, that resulting from the sudden discovery of gold or oil deposits. That did not happen, and, to the best of our knowledge, the economic standards of the communities in the region remained static (and very poor). Thus, we doubt that anemia would have improved if a no-intervention group had been included.
Regression to the mean might have accounted for some of the test-retest increment in hemoglobin concentrations, but true regression to the mean is a time-dependent statistical measure. Over the relatively short intervention Solomons and Schümann describe, regression to the mean would have been negligible. They also suggested that the wide biological variation in capillary finger-stick samples (wider than that in venous samples) might have contributed to the regression to the mean. Again, we disagree. Although we acknowledge the wider variation in capillary samples, the variation may result in either an overestimation or an underestimation of hemoglobin concentration (compared with concentrations in venous samples) and thus would not contribute to a regression to the mean (which would imply a bias only to higher hemoglobin values).
There is nothing in the literature to support Solomons and Schümann's contention that economically disadvantaged infants with anemia due to dietary inadequacy will rapidly improve with no intervention. Thus, although we cannot calculate the attributable change in incidence of anemia in the population we studied, we maintain that the argument against any treatment is fallacious.
Solomons and Schümann question our ability to comment on safety without having included a no-treatment group. They accuse us of "efficacy relativism." We are guilty as charged, but we would argue that we did not include a no-treatment group for the reasons previously outlined and, perhaps more important, that neither ferrous fumarate or sulfate needs the rigorous scrutiny of a "new treatment." Both have been used for decades with documentable side effects such as dark stools, strong metallic taste (ferrous sulfate), staining of teeth (ferrous sulfate drops), and change in gut flora but little else. In sprinkles, ferrous fumarate is coated with a thin layer of soybean lipid to mask the taste of the iron and to prevent changes in the color or taste of the food to which the sprinkles are added. But the form of iron (ferrous fumarate) is not new, and, indeed, in our reported study, given that the fundamental comparison was between the 2 formulations (ferrous sulfate and fumarate), the comparison of diarrhea prevalence was similarly valid.
Solomons and Schümann make the valid point that not all anemias, even in malaria-endemic areas, are due to iron deficiency. We totally agree. Some anemias may be due to blood loss from parasitic infection or to other nutrient deficiencies. One of the advantages of the sprinkles concept is that several micronutrients can be included in the sachet for delivery to the infant. In the current study, we included ascorbic acid to enhance iron absorption. In an ongoing project in Mongolia, we included vitamin D (in addition to iron, ascorbic acid, zinc, vitamin A, and folic acid) in the sachet, because, in Mongolia, anemia and vitamin D deficiency rickets are the 2 most prevalent nutritional problems in children. Thus, we agree with Solomons and Schümann that our study, along with the other studies cited in their letter, "underlies a very important program and policy issue for micronutrient deficiency interventions in developing (and developed) countries…." However, we disagree with their conclusion that "we may be obliged … to screen and diagnose anemias before assigning treatments…." If their conclusion were given credence, the burden of the human and financial costs incurred would literally put a halt to international anemia intervention programs, which are already going at an unacceptably slow pace. Since 1990, when the World Health Assembly on Children proclaimed that the prevalence of anemia should be lower by the year 2000, it has actually increased (8) . Instead of the retrogressive measures suggested by Solomons and Schümann, we believe that there are several innovative interventions on the horizon for anemic infants in malaria-endemic settings, including the Malaria Intermittent Treatment that is being seriously considered by the World Health Organization (9) and the use of sprinkles containing several micronutrients.
Finally, Solomons and Schümann were confused about the description of side effects and adherence to treatment. We originally wrote that "starting 2 wk after baseline and then every 2 wk for the duration of the study, mothers were asked about compliance with treatment over the preceding 7 d, and fieldworkers checked supplies of drops and sachets." We used all of the data from the 4 monitoring visits, and thus the denominator represents the combined data.
Stanley Zlotkin Paul Arthur (deceased)
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